Loading Events

Upcoming Events › Grant

Events Search and Views Navigation

Event Views Navigation

March 2019

FNIH Trailblazer Prize for Clinician-Scientist

March 29

Sponsor: Foundations for the National Institute of Health
Due Date: March 29, 2019
Award: This $10,000 honorarium and prize celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability.

Find out more »

April 2019

Pediatric Epilepsy Research Foundation (PERF) Scientific Grant

April 1

Sponsor: Pediatric Epilepsy Research Foundation
Due Date: April 1, 2019
Award: Supports clinical or basic science research by a child neurologist or developmental pediatrician early in his/her academic career. The selected investigator will receive a $100,000 grant of $50,000 per year for two years. The PERF Grant is supported fully by PERF.

Find out more »

Physician Scientist Fellowship

April 1

Sponsor: Doris Duke Charitable Foundation
Due Date: Opens in April
Award: The Physician Scientist Fellowship consists of $100,000 for annual direct costs plus $10,000 (10 percent) for annual indirect costs for one or two years, depending on the need of the applicant. The priority of the Physician Scientist Fellowship program is to fund outstanding individuals with excitement for clinical research careers, whose projects will address highly significant research questions and lead to career advancement.

Find out more »

Cycle 2: Alzheimer’s Drug Discovery Foundation

April 12

LOI DUE APRIL 12, 2019
Drug Discovery Program
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project depending on the stage of research and must be justified based on the scientific work plan. In some cases, multi-year proposals can be considered.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

ADDF-Harrington Scholar Program

April 12

Sponsor: Alzheimer’s Drug Discovery Foundation
LOI due date: April 12, 2019
Full Application due date: July 19, 2019
Award: Proposals should show potential to advance discovery into meaningful therapeutics designed to treat, prevent, or slow Alzheimer’s disease or related dementias; average award is up to $600,000 over 2 years

Find out more »

CNF Neurodevelopmental Disabilities (NDD) Summer Research Scholarship

April 14

Sponsor: Child Neurology Foundation
Due Date: April 14, 2019
Award: Each year, the CNF offers one summer clinical research scholarship for a first- or second-year U.S. or Canadian medical student who has an interest in training as a child neurologist. The award is made for clinical research focused in the field of neurodevelopmental disabilities in children to be conducted under the direction of a child neurology/NDD subspecialist during summer break. The selected applicant will receive a $3,500 scholarship to support his or her research project.

Find out more »

Cycle 2: Whitehall Foundation Grants-in-Aids

April 15

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: April 15, 2019
Application Due Date: September 1, 2019
Award:  Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Cycle 2: Whitehall Foundation Research Grants

April 15

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: April 15, 2019
Application Due Date: September 1, 2019
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »

May 2019

Cycle 2: Broad PCORI Funding Announcements

May 29

Sponsor: Patient-Centered Outcomes Research Institute
LOI Due Date: May 29, 2019 by 5 pm ET
Application Due Date: September 4, 2019 by 5 pm
Award: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Healthcare Systems: $3 million; Communication & Dissemination Research: $2 million. Maximum project period is 3 years.

Find out more »

July 2019

Cycle 4: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

July 7

Sponsor: National Institutes of Health (multiple Institutes)
LOI Due Date: July 7, 2019
Application Due Date: August 9, 2019
Award: Actual needs; applicants should rarely exceed up to $500,000 total cost per year for Phase I and up to $1,500,000 total cost per year for the Phase II.

Find out more »

Cycle 3: Alzheimer’s Drug Discovery Foundation

July 12

LOI DUE JULY 12, 2019
Drug Discovery Program
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

October 2019

Cycle 3: Whitehall Foundation Grants-in-Aids

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2019
Application Due Date: February 15, 2020
Award:  Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Cycle 3: Whitehall Foundation Research Grants

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2019
Application Due Date: February 15, 2020
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »

Cycle 4: Alzheimer’s Drug Discovery Foundation

October 11

LOI DUE OCTOBER 11, 2019
Drug Discovery Program
The Drug Discovery RFP supports novel drug programs and repurposed/repositioned programs. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

December 2019

Rolling Basis: Alzheimer’s Drug Discovery Foundation

December 31

PROPOSALS ACCEPTED ON A ROLLING BASIS
ADDF/NIH
Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.
Conference Funding
Supports scientific conferences that are relevant to our mission with grants up to $10,000.

Find out more »

January 2020

ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

January 1, 2020

Sponsor: International Rett Syndrome Foundation (IRSF)
Due Date: Applications accepted on a rolling basis
Award: Up to $600,000 over two years

Find out more »

Cycle 1: Whitehall Foundation Grants-In-Aid

January 1, 2020

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: January 15, 2020
Application Due Date: June 1, 2020
Award: Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Cycle 1: Whitehall Foundation Research Grants

January 15, 2020

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: January 15, 2020
Application Due Date: June 1, 2020
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »
+ Export Events